INE376G01013
INE376G01013
BIOCON LIMITED.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 167.799.000.000 | 150.522.000.000 | 11.5% |
| Cost of Revenue | 56.948.000.000 | 51.980.000.000 | 9.6% |
| Gross Profit | 110.851.000.000 | 98.542.000.000 | 12.5% |
| 93.630.000.000 | 82.283.000.000 | 13.8% | |
| Operating Income | 17.221.000.000 | 16.259.000.000 | 5.9% |
| Pretax Income | 4.479.000.000 | 18.866.000.000 | 76.3% |
| Net Income Common Stockholders | 3.856.000.000 | 10.133.000.000 | 61.9% |
| -- | -- | -- | |
| -- | -- | -- |